Internal Medicine, Hematology & Oncology · Bellevue, NE
NPI
1184017618
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2510 Bellevue Medical Center Dr Ste 250
Bellevue, NE, 68123
Phone (402) 559-8013
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
569 services
Medicare patients, 2024
149
Average age 75
Drug cost, 2024
$2.5M
780 prescriptions
Company payments, 2025
$57.65
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harshraj Leuva was code 99215 (office e&m - established), 143 times for 46 patients. In total Harshraj Leuva billed 569 services in 11 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 143 | 46 | $99.09 | $14K |
| 99215 Office E&M - Established | Facility | 114 | 36 | $103.27 | $12K |
| 99214 Office E&M - Established | Office | 92 | 49 | $62.43 | $5,744 |
| 99214 Office E&M - Established | Facility | 61 | 28 | $65.84 | $4,016 |
| 99205 Office E&M - New | Office | 33 | 33 | $124.11 | $4,096 |
| 99223 Hospital E&M - Initial | Facility | 28 | 25 | $126.06 | $3,530 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 24 | 19 | $12.12 | $291 |
| 99443 Telephone Services | Office | 20 | 16 | $63.80 | $1,276 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 19 | 15 | $12.12 | $230 |
| 99205 Office E&M - New | Facility | 19 | 19 | $125.99 | $2,394 |
By year: 2022 $8,366 for 95 services; 2023 $34K for 403 services; 2024 $49K for 569 services.
Medicare prescription drug claims, 2024
In 2024, the drug Harshraj Leuva prescribed most often to Medicare patients was Abiraterone Acetate, with 193 prescriptions and refills. In total Harshraj Leuva wrote 780 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 193 | 193 | 26 | $411K |
| Prednisone Generic | 124 | 224 | 36 | $834 |
| Oxycodone Hcl Generic | 32 | 32 | 11 | $612 |
| Nubeqa Darolutamide | 31 | 31 | Under 11 | $397K |
| Eliquis Apixaban | 28 | 38 | Under 11 | $21K |
| Xtandi Enzalutamide | 28 | 28 | Under 11 | $366K |
| Cabometyx Cabozantinib S-Malate | 21 | 21 | Under 11 | $516K |
| Tamsulosin Hcl Generic | 20 | 44 | Under 11 | $217 |
| Ondansetron Hcl Generic | 18 | 19 | 14 | $221 |
| Pantoprazole Sodium Generic | 16 | 18 | Under 11 | $108 |
| Prochlorperazine Maleate Generic | 16 | 16 | 14 | $162 |
| Pazopanib Hcl Generic | 14 | 14 | Under 11 | $167K |
| Inlyta Axitinib | 12 | 12 | Under 11 | $204K |
| Duloxetine Hcl Generic | 11 | 13 | Under 11 | $219 |
| Betamethasone Dipropionate Generic | 11 | 11 | Under 11 | $567 |
Brand drugs: 159 claims; generic drugs: 621 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harshraj Leuva $57.65 ($57.65 in general payments such as food, travel and fees) from 2 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $57.65.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $57.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.